definiens: shall mean, collectively, an licenses and sublicenses granted to [COMPANY] under the Epitome License Agreement ; 1.70 shall mean the Euro ofthe European Union ; 1.71 shall have the meaning as defined in Section 5.1 ; 1.72 shall mean, collectively, the countries of the European Union ; 1.73 shall mean any Product with respect to which Bradley shall be entitled to the exclusivity, within the Territory, provided for in Section 15.1.1 ; 1.74 shall mean, with respect to any given Product at any given moment in time, any contract for the sale of such Product to which Bradley, any Affiliate or any Sublicensee shall then be a party ; 1 . 75 shall have the meaning as defined in Section 23.3.1 ; 1.76 means the Food and Drug Administration of the United States government ; 1.77 means the treatment of dermatological diseases in humans, including but not limited to EGWandAK ; 1.78 means, with respect to any Patent or Patent Application, any and all out - of - pocket filing and other fees, levies, payments and charges paid to any Governmental Authority in connection with the Prosecution of any such Patent or Patent Application ; 1.79 shall mean the date on which the First Approved Product shall have received Market Approval in the Territory